Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 9, 2022

Eli Lilly launches citrate-free Taltz formulation

Eli Lilly and Company has announced that its Taltz (ixekizumab) 80mg/mL injection is now available in a new, citrate-free formulation.

Eli Lilly launches citrate-free Taltz formulation